The discussion runs from 36 minutes onwards.
Dr Ijeoma Edoka is a principal research consultant at the Health Economics and Epidemiology Research Office, University of the Witwatersrand, Johannesburg and an honorary lecturer at the Wits School of Public Health. Her research interests are broad and have included the application of cost-effectiveness analyses for informing resource allocation decisions in low-and middle-income countries, advancing methods for economic evaluation and the application of quasi-experimental methods for assessing the impact of health policies. She currently leads an assessment of the costs and cost-effectiveness of the COVID-19 vaccination programme South Africa.
ijeoma.edoka@wits.ac.za
Stephen Resch is the Deputy Director of the Center for Health Decision Science (CHDS) and a Lecturer in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health.
sresch@hsph.harvard.edu
Dr Ulla Kou Griffiths is a health economist specializing in the economics of vaccines. She has extensive experience in cost-effectiveness analysis, health outcome measurement and public financial management. At UNICEF HQ, Ulla leads approximately ten staff and consultants who are part of the Immunization Financing Team. Before joining UNICEF in 2016, Ulla worked at the London School of Hygiene and Tropical Medicine for ten years, and before that she was at the WHO in Geneva for six years. She has also worked as a health economist in the Ministry of Health in Guyana (1995-1997). Ulla is originally from Denmark and holds an MSc in Economics from Copenhagen University and a PhD from LSHTM.